Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

Chief Executive Officer Kumar Neil converted options into 64,697 shares and covered exercise/tax liability with 32,855 shares, increasing direct ownership by 14% to 254,932 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.